impact of metabolic syndrome on response to intradermal injection of dutastride in patients with female pattern hair loss

Impact of metabolic syndrome on response to intradermal injection of dutastride 0.02% in patients with female pattern hair loss; a prospective randomized controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201806003307977

Enrollment

Registered

2018-04-06

Start date

2018-04-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine female pattern hair loss

Interventions

0.02% dutastride

0.02% dutastride/ metabolic syndrome

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: grade I and II of female pattern hair loss age 18-50 years

Exclusion criteria

Exclusion criteria: male patients age 50 years grade III and IV of female pattern hair loss patients with history of hypersensitivity to dutastride other types of alopecia pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
degree of improvement;patient`s satisfaction	—

Secondary

Measure	Time frame
Persistence of the response, improvement, or worsening	—

Countries

Egypt

Contacts

Public ContactRania Madi

Faculty of Medicine for Girls, Al-Azhar University

rania_abdulghani@hotmail.com+2-01283433887

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026